Clinical trial

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV…

NCT00476463 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed

Key facts

NCT number NCT00476463
Title Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection
Official title Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naive Patients With HIV/HBV Co-infection
Lead sponsor The HIV Netherlands Australia Thailand Research Collaboration, Other
Collaborators Gilead Sciences Industry Ministry of Health, Thailand
Status Completed
Phase Phase 2
Study type Interventional
Conditions Hepatitis B Virus, HIV Infections
Intervention type Drug
Interventions Emtricitabine
Enrollment 24
Start date Apr 1, 2005
Primary completion Dec 1, 2008
Completion Dec 1, 2008
First posted May 22, 2007
Last update posted Feb 22, 2016
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies